Vaccine profile of herpes zoster (HZ/su) subunit vaccine.

Abstract:

INTRODUCTION:Herpes zoster (HZ) causes an often severe and painful rash in older people and may be complicated by prolonged pain (postherpetic neuralgia; PHN) and by dissemination in immune-compromised patients. HZ results from reactivation of latent varicella-zoster virus (VZV) infection, often associated with age-related or other causes of decreased T cell immunity. A live attenuated vaccine boosts this immunity and provides partial protection against HZ, but this decreases with age and declines over 8 years. Areas covered: A new HZ subunit (HZ/su) vaccine combines a key surface VZV glycoprotein (E) with a T cell-boosting adjuvant system (AS01B) and is administered by two intramuscular injections two months apart. Expert commentary: HZ/su showed excellent efficacy of ~90% in immunocompetent adults ≥50 and ≥70 years of age, respectively, in the ZOE-50 and ZOE-70 phase III controlled trials. Efficacy was unaffected by advancing age and persisted for >3 years. Approximately 9.5% of subjects had severe, but transient (1-2 days) injection site pain, swelling or redness. Compliance with both vaccine doses was high (95%). The vaccine will have a major impact on HZ management. Phase I-II trials showed safety and immunogenicity in severely immunocompromised patients. Phase III trial results are expected soon.

journal_name

Expert Rev Vaccines

authors

Cunningham AL,Heineman T

doi

10.1080/14760584.2017.1329012

subject

Has Abstract

pub_date

2017-07-01 00:00:00

pages

1-10

issue

7

eissn

1476-0584

issn

1744-8395

journal_volume

16

pub_type

杂志文章,评审
  • Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution.

    abstract:INTRODUCTION:Pneumococcal conjugate vaccine (PCV) impact studies have reported substantial reductions in the incidence of invasive pneumococcal disease (IPD) after implementation of childhood PCV programs. Heterogeneity in surveillance systems, local epidemiology and PCV programs hampers comparisons between studies. We...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2018.1413354

    authors: Izurieta P,Bahety P,Adegbola R,Clarke C,Hoet B

    更新日期:2018-06-01 00:00:00

  • Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma.

    abstract::There is growing interest in immunotherapy for malignant gliomas. This interest stems from a number of immunological observations, together with the failure of conventional therapeutic agents to produce broad and clinically meaningful improvements in survival and quality of life. The challenges faced in translating la...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2014.881255

    authors: Fenstermaker RA,Ciesielski MJ

    更新日期:2014-03-01 00:00:00

  • Current challenges in the development of vaccines for pneumonic plague.

    abstract::Inhalation of Yersinia pestis bacilli causes pneumonic plague, a rapidly progressing and exceptionally virulent disease. Extensively antibiotic-resistant Y. pestis strains exist and we currently lack a safe and effective pneumonic plague vaccine. These facts raise concern that Y. pestis may be exploited as a bioweapon...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.7.2.209

    authors: Smiley ST

    更新日期:2008-03-01 00:00:00

  • Assessing readiness to implement routine immunization among patent and proprietary medicine vendors in Kano, Nigeria: a theory-informed cross-sectional study.

    abstract:BACKGROUND:Patent and proprietary medicine vendors (PPMVs) are widespread in communities and can potentially be used to expand access to routine immunization especially in underserved areas. In this study, we aimed to assess their readiness to implement routine immunization in Kano, Nigeria and identify factors associa...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章

    doi:10.1080/14760584.2020.1750379

    authors: Adamu AA,Gadanya MA,Jalo RI,Uthman OA,Nnaji CA,Bello IW,Wiysonge CS

    更新日期:2020-04-01 00:00:00

  • Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics.

    abstract:INTRODUCTION:Intranasal influenza vaccines are expected to confer protection among vaccine recipients by successful induction of mucosal immune response in the upper respiratory tract. Though only live attenuated influenza virus vaccines (LAIVs) are licensed and available for intranasal use in humans today, intranasal ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2018.1507743

    authors: Sano K,Ainai A,Suzuki T,Hasegawa H

    更新日期:2018-08-01 00:00:00

  • Development of Group A streptococcal vaccines: an unmet global health need.

    abstract::Group A Streptococcus (GAS) infections are a significant global cause of morbidity and mortality. GAS diseases disproportionally affect those living in conditions characterized by poverty and social injustice, in both developing countries and in marginalized populations of industrialized nations. In Australia and New ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2016.1116946

    authors: Sheel M,Moreland NJ,Fraser JD,Carapetis J

    更新日期:2016-01-01 00:00:00

  • Generating humoral immune memory following infection or vaccination.

    abstract::The production of long-lived, high-affinity antibodies forms the basis of many successful vaccination strategies. Although much is known of the proteins and pathways of the immune system that lead to the production of these antibodies, there are also many processes that remain unexplained or poorly explained. Some vac...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.10.103

    authors: Randall KL

    更新日期:2010-09-01 00:00:00

  • Cross-protective immunity to influenza A viruses.

    abstract::Antigenic changes in influenza virus occur gradually, owing to mutations (antigenic drift), and abruptly, owing to reassortment among subtypes (antigenic shift). Availability of strain-matched vaccines often lags behind these changes, resulting in a shortfall in public health. In animal models, cross-protection by vac...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.10.123

    authors: Epstein SL,Price GE

    更新日期:2010-11-01 00:00:00

  • Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells.

    abstract::Therapeutic prospects of particulates are increasingly recognized for vaccination purposes. Compared with biologic particulates, such as live or attenuated bacterial vectors and viral vectors, synthetic particulates may be expected to ease the hurdles of quality assurance and validation in vaccine development and prod...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.1.2.215

    authors: Thiele L,Merkle HP,Walter E

    更新日期:2002-08-01 00:00:00

  • International Dengue Vaccine Communication and Advocacy: Challenges and Way Forward.

    abstract::Dengue vaccine introduction will likely occur soon. However, little has been published on international dengue vaccine communication and advocacy. More effort at the international level is required to review, unify and strategically disseminate dengue vaccine knowledge to endemic countries' decision makers and potenti...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2016.1152187

    authors: Carvalho A,Van Roy R,Andrus J

    更新日期:2016-01-01 00:00:00

  • The challenge of assessing infant vaccine responses in resource-poor settings.

    abstract::Newborns and infants are highly susceptible to infectious diseases, resulting in high mortality and morbidity, particularly in resource-poor settings. Many vaccines require several booster doses, resulting in an extensive vaccine schedule, and yet there is still inadequate protection from some of these diseases. This ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.10.41

    authors: Flanagan KL,Burl S,Lohman-Payne BL,Plebanski M

    更新日期:2010-06-01 00:00:00

  • Optimizing cellular immunity against HIV-1 Gag and preventing suppression by HIV-1 gp120.

    abstract::Evaluation of: Böckl K, Wild J, Bredl S et al. Altering an artificial Gagpolnef polyprotein and mode of Env co-administration affects the immunogenicity of a clade C HIV-1 DNA vaccine. PLoS ONE 7(4), e34723 (2012). SIV vaccination studies in monkeys have revealed that Env-directed antibodies are critical for protect...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章

    doi:10.1586/erv.12.102

    authors: van Montfort T,Sanders RW

    更新日期:2012-10-01 00:00:00

  • An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.

    abstract::With the exception of alum, emulsion-based vaccine adjuvants have been administered to far more people than any other adjuvant, especially since the 2009 H1N1 influenza pandemic. The number of clinical safety and immunogenicity evaluations of vaccines containing emulsion adjuvants has correspondingly mushroomed. In th...

    journal_title:Expert review of vaccines

    pub_type: 历史文章,杂志文章,评审

    doi:10.1586/14760584.2013.811188

    authors: Fox CB,Haensler J

    更新日期:2013-07-01 00:00:00

  • TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine.

    abstract::Vaccination has been a successful tool in the protection against many infectious diseases, and recent advances in biotechnology have created new techniques and strategies to produce safe and efficacious vaccines for human use. However, developing a protective vaccine against malaria has been a challenge. In this artic...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.10.60

    authors: Coban C,Horii T,Akira S,Ishii KJ

    更新日期:2010-07-01 00:00:00

  • Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection.

    abstract::Notifications of infant deaths, assumed to be related to the introduction of new pentavalent DTwP-Hib-HBV childhood vaccines, caused, during 2008-2010 in few Asian countries, temporary interruptions of the respective vaccination programs. The sudden appearance of fatal cases was due to increased awareness/publicity an...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章

    doi:10.1586/14760584.2015.1059759

    authors: Herzog C

    更新日期:2015-01-01 00:00:00

  • Current and emerging immunotherapeutic approaches to treat and prevent peanut allergy.

    abstract::Peanut-allergen hypersensitivity reactions, which can result in anaphylactic episodes and death, affect approximately 1% of the general population. Currently, strict avoidance of allergenic food is the only available treatment for this food-induced allergic reaction; however, the innocuous presence of trace amounts of...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.12.119

    authors: Miller DS,Brown MP,Howley PM,Hayball JD

    更新日期:2012-12-01 00:00:00

  • Vaccination and healthy aging.

    abstract::The aging process in humans is associated with a decrease in immune function (immunosenescence) and an increase in comorbid disorders. When combined with environmental factors this can lead to an increased risk and severity of infectious diseases. Diseases in older adults (>/=70 years) tend to be more severe and have ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.10.26

    authors: Maggi S

    更新日期:2010-03-01 00:00:00

  • Immunogenicity, effectiveness and safety of combined hepatitis A and B vaccine: a systematic literature review.

    abstract:BACKGROUND:Hepatitis A and B are two of the most common vaccine-preventable diseases and vaccination for Hepatitis A virus (HAV) and hepatitis B virus (HBV) is recommended for those at risk of contracting HAV and/or HBV through their occupation, travel or lifestyle. OBJECTIVE:To describe the vaccine efficacy, immunoge...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2016.1150182

    authors: Bakker M,Bunge EM,Marano C,de Ridder M,De Moerlooze L

    更新日期:2016-07-01 00:00:00

  • Overview of mimotopes and related strategies in tumor vaccine development.

    abstract::Tumor vaccine has been studied extensively as an alternative or adjuvant therapy in the treatment of malignant tumors in the hope of prolonging the overall survival rates of cancer patients. The efficacy largely relies on the specificity of the target. In the last decade, many antibody epitopes, called mimotopes, have...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.7.10.1547

    authors: Zhao L,Liu Z,Fan D

    更新日期:2008-12-01 00:00:00

  • Protein/peptide and DNA vaccine delivery by targeting C-type lectin receptors.

    abstract::C-type lectin receptors (CLRs) are a class of pathogen-recognition receptors that are actively investigated in the field of vaccine delivery. Many of their properties have functions linked to the immune system. These receptors are expressed abundantly on antigen-presenting cells and are considered to be the sentinels ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.7.7.1005

    authors: Tang CK,Sheng KC,Apostolopoulos V,Pietersz GA

    更新日期:2008-09-01 00:00:00

  • Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.

    abstract::As the Global Polio Eradication Initiative progresses toward the eradication of wild polioviruses, national and global health leaders must still actively consider options for managing poliovirus risks, including risks associated with using oral poliovirus vaccine. Oral poliovirus vaccine continues to represent a highl...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/erv.11.195

    authors: Thompson KM,Tebbens RJ

    更新日期:2012-04-01 00:00:00

  • The value of HIV protective epitope research for informed vaccine design against diverse viral pathogens.

    abstract::The success of vaccine regimens against viral pathogens hinges on the elicitation of protective responses. Hypervariable pathogens such as HIV avoid neutralization by masking protective epitopes with more immunogenic decoys. The identification of protective, conserved epitopes is crucial for future vaccine candidate d...

    journal_title:Expert review of vaccines

    pub_type: 社论

    doi:10.1586/14760584.2014.928597

    authors: Kramer VG,Byrareddy SN

    更新日期:2014-08-01 00:00:00

  • Typhoid vaccination: the Asian experience.

    abstract::The WHO has recently issued updated recommendations for the programmatic use of new-generation typhoid vaccines in high-risk areas of countries where typhoid fever is still endemic. Countries have subsequently been instructed to discuss how these recommendations can be implemented and to develop plans for targeted typ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.7.5.547

    authors: DeRoeck D,Ochiai RL,Yang J,Anh DD,Alag V,Clemens JD

    更新日期:2008-07-01 00:00:00

  • Stress and antibody response to vaccination: implications of animal studies for human clinical research.

    abstract::Psychological stress has been shown to be associated with poorer antibody levels following vaccination in both animals and humans, although the mechanisms underlying this relationship remain unclear. However, animal research has enabled investigation of how this relationship may be affected by the influence of individ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.3.2.141

    authors: Burns V

    更新日期:2004-04-01 00:00:00

  • Recombinant cancer vaccines and new vaccine targets. Interview by Jenaid Rees.

    abstract::Interview by Jenaid Rees, Commissioning Editor Jeffrey Schlom obtained his PhD from Rutgers University (NJ, USA). After obtaining his PhD, he worked at Columbia University (NY, USA) before moving in 1973 to the National Cancer Institute, National Institutes of Health (MD, USA). Since then he has served as the Chief of...

    journal_title:Expert review of vaccines

    pub_type: 传,历史文章,面试

    doi:10.1586/14760584.2013.836913

    authors: Schlom J

    更新日期:2013-10-01 00:00:00

  • Challenges in estimating influenza vaccine effectiveness.

    abstract::Introduction: Influenza vaccination is regarded as the most effective way to prevent influenza infection. Due to the rapid genetic changes that influenza viruses undergo, seasonal influenza vaccines must be reformulated and re-administered annually necessitating the evaluation of influenza vaccine effectiveness (VE) e...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1080/14760584.2019.1622419

    authors: Ainslie KEC,Haber M,Orenstein WA

    更新日期:2019-06-01 00:00:00

  • Antigen delivery systems.

    abstract::Many vaccine candidates are highly purified, sometimes monomeric antigens and as a result, not very immunogenic. Antigen delivery systems optimize the presentation of antigens. They also play a major role in solving the problem of there being an increasing number of vaccines but limited opportunities in which to inclu...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.3.4.453

    authors: Kersten G,Hirschberg H

    更新日期:2004-08-01 00:00:00

  • Vaccines in leishmaniasis: advances in the last five years.

    abstract::The leishmaniases are a group of diseases caused by protozoa of the genus Leishmania which affects millions of people worldwide. The leishmaniases are transmitted to the vertebrate hosts by phlebotomine sand flies. In this review, we focus on clinical aspects of the leishmaniases and on the immune response against the...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章,评审

    doi:10.1586/14760584.2.5.705

    authors: Brodskyn C,de Oliveira CI,Barral A,Barral-Netto M

    更新日期:2003-10-01 00:00:00

  • What can be done to make vaccines more trendy?

    abstract::Incredibly, vaccines currently capture only about 2% of the world's pharmaceutical market, despite the fact that they can be credited with saving more lives and preventing more suffering and disability than any other form of medical activity, with the possible exception of the provision of clean water. ...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章

    doi:10.1586/14760584.4.1.23

    authors: Andre FE

    更新日期:2005-02-01 00:00:00

  • Serotype distribution and penicillin-non-susceptibility of Streptococcus pneumoniae causing invasive diseases in Kuwait: A 10-year study of impact of pneumococcal conjugate vaccines.

    abstract:OBJECTIVES:The impact of PCV7 and PCV13 on pneumococcal infections in Kuwait is not known. Therefore we evaluated the impact on pneumococcal serotype distribution and penicillin-non-susceptibility in invasive infections in Kuwait. METHODS:Children < 2 y were given PCV7 from Aug 2006 to Jul 2010 (period I), and PCV13 f...

    journal_title:Expert review of vaccines

    pub_type: 杂志文章

    doi:10.1080/14760584.2016.1198698

    authors: Mokaddas E,Albert MJ

    更新日期:2016-10-01 00:00:00